Home › Overweight › North Carolina › Wilmington

Pag-aaral pangklinika para sa Overweight sa Wilmington, NC

Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Wilmington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2

Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07752979

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Nagre-recruitPhase 3

Accellacare - Wilmington, Wilmington
Jeffrey Coleman, OD, Wilmington

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07595549

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Nagre-recruitPhase 2

TMA Headlands, Wilmington

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Nagre-recruitPhase 3

Trial Management Associates - Wilmington - Floral Parkway, Wilmington

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Nagre-recruitPhase 3

Accellacare and KDCILM, LLC, Wilmington

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Nagre-recruitPhase 3

Accellacare - Wilmington - 1917 Tradd Court, Wilmington

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Nagre-recruitPhase 3

Trial Management Associates - Wilmington - Floral Parkway, Wilmington

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Nagre-recruitPhase 3

KDCILM, LLC & Accellacare US, Inc., Wilmington

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07745504

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Nagre-recruitPhase 3

Accellacare Research of Wilmington, Wilmington

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Nagre-recruitPhase 3

ACCOMPLISH-1 Research Site, Wilmington

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Nagre-recruitPhase 1

Accellacare, Wilmington

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT07607587

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Wilmington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.